Back to Journals » OncoTargets and Therapy » Volume 16

Case report

Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer

       
Total article views   HTML views PDF downloads Totals
2,150 Dovepress* 2,041+ 57 2,098
PubMed Central* 109 34 143
Totals 2,150 91 2,241
*Since 29 November 2023

View citations on PubMed Central and Google Scholar